Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients

Immune checkpoint inhibitors (ICIs) are emerging as the new standard of care for treating various metastatic cancers. It is known that effective anti-tumor immune responses are associated with a stronger presence of tumor-infiltrating lymphocytes (TILs) in solid tumor tissue. Cancer patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan Ali, Omar, Berner, Fiamma, Ackermann, Christoph Jakob, Ring, Sandra Stephanie, Moulin, Alexandre, Müller, Joachim, Markert, Eva, Pop, Oltin Tiberiu, Müller, Stefanie, Diem, Stefan, Hundsberger, Thomas, Flatz, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889549/
https://www.ncbi.nlm.nih.gov/pubmed/32804246
http://dx.doi.org/10.1007/s00262-020-02693-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889549/
https://www.ncbi.nlm.nih.gov/pubmed/32804246
http://dx.doi.org/10.1007/s00262-020-02693-7

Ejemplares similares